Click image to view full size image
Raw Steroid Powders Raloxifene Hydrochloride 82640 - 04 - 8 Prevention Of Osteoporosis
Detailed Product Description
Raloxifene (marketed as Evista by Eli Lilly and Company) is an oral selective estrogen receptor modulator (SERM) that has estrogenic actions on bone and anti-estrogenic actions on the uterus and breast. It is used in the prevention of osteoporosis in postmenopausal women.
Raloxifene hydrochloride-- Quick Detail :
Raloxifene hydrochloride -- Raloxifene hydrochloride
Raloxifene hydrochloride -- Alias: Raloxifene HCL;KEOXIFENE;AKOS 92138
Raloxifene hydrochloride -- CAS Registry Number:82640-04-8
Raloxifene hydrochloride -- Purity: 99%
Raloxifene hydrochloride -- MF: C28H28ClNO4S
Raloxifene hydrochloride -- MW: 510.04
Raloxifene hydrochloride -- Appearance:light yellow powder
Raloxifene hydrochloride -- Related Substances : Pharmaceutical Grade
Raloxifene hydrochloride -- Storage: Shading, confined preservation
Raloxifene hydrochloride -- Usage :It is used in the prevention of osteoporosis in postmenopausal women.
Skype:sucy1171
E -mail:pharmacy@ycgmp.com
Whatsapp:+8618565342920
Raloxifene hydrochloride-- Description:
Evista is Eli Lilly & Companys brand name for raloxifen hydrochloride, a second-generation Selective Estrogen Receptor Modulator (SERM) in the Raloxifene hydrochloridebenzothiophene family. On September 13, 2007, the U. S. Food and Drug Raloxifene hydrochloride Administration approved Evista for reduction in the risk of invasive breast cancer in postmenopausal women with and Raloxifene hydrochloride without osteoporosis. It has also been approved as a potent stand-alone osteoporosis treatment.Raloxifene hydrochloride
Raloxifene hydrochloride-- Applications:
Raloxi
Raw Steroid Powders Raloxifene Hydrochloride 82640 - 04 - 8 Prevention Of Osteoporosis
